This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
2g | $250 | Check With Us |
5g | $500 | Check With Us |
10g | $750 | Check With Us |
Cat #: V3975 CAS #: 1421373-66-1 Purity ≥ 98%
Description: Osimertinib mesylate (formerly known as AZD9291; AZD-9291; AZD 9291; mereletinib; Tagrisso), the mesylate salt of osimertinib, is a novel, potent, oral bioavailable, irreversible, and mutant-selective, 3rd generation EGFR inhibitor approved by both FDA and the European Commission for cancer treatment.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 595.72 |
---|---|
Molecular Formula | C29H37N7O5S |
CAS No. | 1421373-66-1 |
Storage | -20℃ for 3 years in powder formr |
-80℃ for 2 years in solvent | |
Solubility In Vitro | DMSO: > 100mg/mLr |
Water: N/Ar | |
Ethanol: N/A | |
Solubility In Vivo | 1% DMSO+30% PEG 300+dd H2O: 30mg/mL |
SMILES Code | CN(CCN(C)C)C1=CC(OC)=C(C=C1NC(C=C)=O)NC2=NC=CC(C3=CN(C)C4=C3C=CC=C4)=N2.OS(=O)(C)=O |
Synonyms | AZD-9291 mesylate; Mereletinib mesylate; AZD9291; AZD 9291; Trade name: Tagrisso |
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 1.6786 mL | 8.3932 mL | 16.7864 mL | 33.5728 mL |
5mM | 0.3357 mL | 1.6786 mL | 3.3573 mL | 6.7146 mL |
10mM | 0.1679 mL | 0.8393 mL | 1.6786 mL | 3.3573 mL |
20mM | 0.0839 mL | 0.4197 mL | 0.8393 mL | 1.6786 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.